查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1990300

内视镜闭合装置市场：2026-2032年全球市场预测（依产品类型、闭合机制、材料、应用及最终用户划分）

Endoscopic Closure Devices Market by Product Type, Closure Mechanism, Material, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，内视镜闭合装置市场价值将达到 5.7077 亿美元，到 2026 年将成长至 6.0204 亿美元，到 2032 年将达到 8.6462 亿美元，复合年增长率为 6.11%。

主要市场统计数据
基准年 2025 570,770,000 美元
预计年份：2026年 6.0204亿美元
预测年份 2032 8.6462亿美元
复合年增长率 (%) 6.11%

不断提高的临床期望、技术协同效应以及相关人员的经济因素如何重新定义内视镜闭合装置市场的优先事项。

在临床需求和器械创新共同推动下，内视镜闭合装置已从辅助器具发展成为治疗性内视镜工作流程的核心组成部分。随着微创手术范围和复杂性的增加，临床医生需要可预测且持久的闭合解决方案，以降低併发症率、缩短恢復时间并扩大内视镜介入治疗的适用人群。能源来源、成像系统和配套工具包的进步正在影响器械的形状和手术通讯协定，促使製造商重新评估设计重点，例如输送方式、易用性和与现有内视镜的兼容性。

临床领域的扩展、整合设备平台的整合以及对实证监管的重视，正在重塑竞争重点和产品蓝图。

近年来，临床实务、技术整合和法律规范都发生了变革性变化，这些变化共同重塑了内视镜闭合装置的格局。临床上，内视镜手术范围的不断扩大，从高级止血和穿孔处理到肥胖症治疗性介入，推动了对多功能闭合解决方案的需求，这些解决方案需能可靠地应用于各种组织类型和手术情况。这促使人们增加对输送系统、材料科学和使用者介面设计的技术投入，旨在减少植入差异并扩大适应症。

关税政策的波动促使企业进行策略性供应链多元化、近岸外包倡议，并重新评估整个设备组合的采购经济效益。

随着美国将于2025年实施新的关税措施，製造商和医疗保健供应商的供应链和产业计画将变得更加复杂。关税调整可能会影响进口零件和成品的到货成本，因此需要重新评估筹资策略和成本转嫁决策。为此，医疗设备开发商和经销商正在审查其采购流程，以确保关键手术用品的供应连续性，同时尽可能减少利润率的下降。

进行详细的細項分析，以确定每种医疗设备类型、临床环境、作用机制和材料考量的明确需求驱动因素。

观点分析揭示了每种产品类型、最终用户、应用、闭合机制和材料的不同需求驱动因素和创新路径。产品分类包括夹子、密封剂和缝合线，每种分类包含各自独特的亚型，具有各自独特的临床应用。夹子分为金属和聚合物两种类型；金属夹子通常用于持久的机械固定，而聚合物夹子则常用于减少伪影并提高在特定组织类型中的贴合度。密封剂包括生物衍生的纤维蛋白製剂和合成黏合剂。纤维蛋白基产品因其生物相容性和止血效果而备受青睐，而合成黏合剂提供针对特定应用的固化特性和操作性能。缝合线分为可吸收缝合线和不可吸收缝合线；可吸收缝合线为癒合提供可吸收的组织支撑，而不可吸收缝合线则在需要长期组织暴露时提供持续的抗拉强度。

区域趋势和医疗保健系统优先事项的差异正在决定封闭式技术采用途径和打入市场策略的多样化。

区域趋势影响内视镜闭合装置的创新、应用和商业策略，美洲、欧洲、中东和非洲以及亚太地区呈现出截然不同的模式。在美洲，先进科技的应用和一体化医疗服务网络为那些展现出高效操作和明确治疗效果的装置创造了机会。同时，控製成本的压力和支付方的严格审查促使人们更加关注循证医学的产生以及整个医疗过程的整体价值。该地区的法规结构和报销环境尤其重视可靠的临床数据和清晰的手术编码系统。

竞争格局的特点是：成熟企业利用规模优势，敏捷的创新者，以及优先考虑基于证据、服务和系统层面价值的协作策略。

该行业的竞争格局由成熟的医疗设备製造商、细分领域的专业公司和灵活的Start-Ups组成，它们在创新和市场准入方面各有优势。老字型大小企业通常利用规模、分销网络和综合临床支援项目，确保其产品在高流量手术中心获得成功部署。这些企业通常会投资于产品改进、广泛的临床试验以及全面的培训课程，以降低跨学科团队部署的障碍。

为製造商和供应商提供切实可行的策略措施，以使产品开发、证据产生和供应弹性与不断变化的临床需求保持一致。

产业领导企业可以采取一系列切实可行的措施来应对临床、商业性和营运方面的复杂挑战，同时加速推广有效的闭合解决方案。首先，他们可以透过使研发投资与可验证的临床需求保持一致，提高高频手术场所的采用率，例如提高在发炎组织内部署的可靠性，以及实现在狭窄解剖结构内进行低轮廓输送。优先考虑以使用者为中心的设计，并投资于基于模拟器的训练模组，可以缩短学习曲线，并提高治疗的一致性，而无需考虑操作者的技能水平。

为确保研究结果具有可操作性和检验，我们采用了严格的混合研究框架，该框架结合了主要临床发现、监管审查和供应链映射。

本分析所依据的研究采用混合方法，旨在产生可靠且可操作的见解，同时保持透明度和可重复性。主要研究包括对第一线内视镜医师、外科负责人、采购负责人和设备开发人员进行深度访谈，以了解他们对临床需求、设备性能和采购决策者的原有观点。这些定性资讯与设备使用手册、监管申报文件和同行评审的临床文献进行交叉比对，以检验性能声明并识别证据缺口。

随着技术、临床和营运重点的融合，不断发展的血管闭合装置市场的成功被认为取决于综合的、以证据主导的策略。

内视镜闭合装置的未来发展将受到临床创新、实证医学需求和操作需求三者共同影响。随着手术复杂性的增加和医疗相关人员对可验证价值的要求日益提高，成功的器械策略需要具备以下要素：稳定的临床表现、透过有效的教育支持推广应用以及稳健的供应链。材料科学的进步、输送机制的改进以及与内视镜平台更紧密的整合将持续拓展其临床效用。然而，这些技术进步必须辅以严谨的系统性获益证据，才能确保其广泛应用。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 内视镜闭合装置市场：依产品类型划分

  • 夹子
    • 金属夹
    • 聚合物夹
  • 密封剂
    • 纤维蛋白胶
    • 合成黏合剂
  • 缝合线
    • 可吸收缝线
    • 不可吸收缝线

第九章 依闭合机制分類的内视镜闭合装置市场

  • 黏合封口
    • 注射式黏合剂
    • 局部黏合剂
  • 机械闭合
    • 夹子已关闭
    • 缝合闭合

第十章 内视镜闭合装置市场：依材料分类

  • 金属
  • 聚合物

第十一章 内视镜闭合装置市场：依应用领域划分

  • 肥胖症治疗
  • 消化系统

第十二章 内视镜闭合装置市场：依最终用户划分

  • 门诊手术中心
  • 诊所
  • 医院

第十三章 内视镜闭合装置市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 内视镜闭合器械市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 内视镜闭合器械市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国内视镜闭合装置市场

第十七章：中国内视镜闭合器材市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • Ackermann Instrumente GmbH
  • Ambu A/S
  • Apollo Endosurgery Inc
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Cardinal Health Inc
  • CONMED Corporation
  • Cook Medical LLC
  • CooperSurgical Inc
  • ENDO-FLEX GmbH
  • EndoGastric Solutions Inc
  • Ethicon Inc
  • Fujifilm Holdings Corporation
  • Hoya Corporation
  • Karl Storz SE & Co. KG
  • Medtronic plc
  • Meril Life Sciences Pvt. Ltd.
  • Micro-Tech Endoscopy USA Inc
  • Olympus Corporation
  • Ovesco Endoscopy AG
  • Richard Wolf GmbH
  • Smith & Nephew plc
  • STERIS plc
  • Teleflex Inc
Product Code: MRR-CB04E05659AA

The Endoscopic Closure Devices Market was valued at USD 570.77 million in 2025 and is projected to grow to USD 602.04 million in 2026, with a CAGR of 6.11%, reaching USD 864.62 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 570.77 million
Estimated Year [2026] USD 602.04 million
Forecast Year [2032] USD 864.62 million
CAGR (%) 6.11%

How accelerating clinical expectations, technological synergies, and stakeholder economics are redefining priorities in the endoscopic closure device landscape

Endoscopic closure devices have moved from niche adjuncts to core components of therapeutic endoscopy workflows, driven by converging clinical needs and device innovation. As minimally invasive procedures expand in scope and complexity, clinicians require predictable, durable closure solutions that reduce complication rates, shorten recovery times, and expand the eligible patient population for endoscopic interventions. The evolution of energy sources, imaging systems, and accessory toolkits has influenced device form factors and procedural protocols, prompting manufacturers to rethink design priorities such as delivery profile, ease of deployment, and compatibility with existing endoscopes.

Concurrently, stakeholder expectations have shifted. Hospital administrators emphasize device cost-effectiveness and procedural throughput, while payers and regulators increasingly scrutinize safety evidence and real-world outcomes. These pressures are reshaping procurement criteria and catalyzing cross-disciplinary collaboration among gastroenterologists, bariatric surgeons, and interventional endoscopists. As a result, the competitive landscape now rewards suppliers who can demonstrate not only clinical efficacy but also robust training programs, service reliability, and clear value propositions tied to patient pathways.

This introduction summarizes the forces that are steering product development and commercial strategy in endoscopic closure technologies. With a sharper focus on reproducibility, ease of use, and integrated procedural solutions, the field is entering a phase where incremental device enhancements will be judged on their ability to deliver measurable improvements in clinical workflow and patient-centered outcomes.

Clinical expansion, integrated device-platform convergence, and evidence-driven regulatory emphasis are reshaping competitive priorities and product roadmaps

Recent years have seen transformative shifts across clinical practice, technology integration, and regulatory oversight that collectively reshape the endoscopic closure device landscape. Clinically, the broadening scope of endoscopic therapeutic procedures-spanning advanced hemostasis, perforation management, and bariatric interventions-has driven demand for versatile closure solutions that perform reliably across variable tissue types and procedural contexts. This has incentivized engineering investments in delivery systems, material science, and user-interface design aimed at reducing deployment variability and expanding indications.

On the technology front, improvements in visualization, navigation, and device ergonomics have enabled tighter integration between closure tools and procedural workflows. Enhanced endoscopic platforms provide higher fidelity imaging and more precise control, which in turn allow closure devices to be optimized for smaller working channels and complex anatomies. These synergies are encouraging manufacturers to pursue collaborative product roadmaps and platform-compatible accessories rather than standalone instruments.

Regulatory and reimbursement trends are also exerting influence. Agencies are increasingly focused on post-market surveillance and real-world evidence, prompting device developers to prioritize registries and clinical partnerships that can substantiate safety profiles over time. Payers are similarly attentive to longitudinal outcomes, which has elevated the importance of demonstrating reductions in readmissions, secondary interventions, and total episode-of-care costs. Together, these shifts are driving a market environment where clinical versatility, evidence generation, and system-level value are central to competitive differentiation.

Shifts in tariff policy are prompting strategic supply chain diversification, nearshoring initiatives, and reassessment of procurement economics across device portfolios

The imposition of new tariff measures in the United States for the year 2025 has injected an additional layer of complexity into supply chain and commercial planning for manufacturers and healthcare providers. Tariff adjustments can alter landed costs for imported components and finished devices, prompting reassessment of sourcing strategies and cost pass-through decisions. In response, device developers and distributors are recalibrating procurement processes to mitigate margin erosion while preserving supply continuity for critical procedural items.

Strategically, the tariff environment is accelerating two complementary responses: diversification of supplier bases and selective nearshoring of manufacturing activities. Diversification reduces single-supplier exposure and enhances resilience to customs or logistics disruptions. Nearshoring and regional production can insulate companies from tariff volatility, shorten lead times, and simplify regulatory compliance across key markets. These shifts are not purely operational; they also influence product lifecycle economics and commercial planning, including inventory policies, contractual terms with health systems, and portfolio prioritization.

From a commercial perspective, end users and group purchasing organizations are re-evaluating procurement criteria to balance total cost of ownership with clinical performance. For some stakeholders, the tariff-driven rise in import costs may accelerate adoption of domestically produced alternatives or variants that optimize material usage without compromising clinical outcomes. Overall, the tariff landscape is prompting more dynamic supply chain strategies and closer alignment between operations, regulatory affairs, and commercial leadership to safeguard access to essential closure devices.

Detailed segmentation analysis revealing distinct demand drivers across device types, clinical settings, mechanism choices, and material considerations

A granular view of segmentation exposes differentiated demand drivers and innovation pathways across product types, end users, applications, closure mechanisms, and materials. Product classifications include clips, sealants, and sutures, each with internal subtypes that have distinct clinical applications. Clips are available as metal and polymer variants, with metal clips often selected for durable mechanical fixation and polymer clips for reduced artifact and improved conformability in certain tissue types. Sealants encompass biologic fibrin formulations and synthetic adhesives, where fibrin-based products are favored for biocompatibility and hemostatic support while synthetic adhesives offer tailored curing profiles and handling characteristics. Sutures bifurcate into absorbable and non-absorbable options, with absorbable sutures providing resorbable tissue support for healing and non-absorbable sutures delivering prolonged tensile strength where extended approximation is required.

End users span ambulatory surgical centers, clinics, and hospitals, and each setting imposes distinct constraints on device selection. Ambulatory surgical centers and outpatient clinics prioritize rapid setup, ease of use, and disposability to support high throughput and predictable procedure times. Hospitals, particularly tertiary centers, value versatility, documented clinical outcomes across complex procedures, and integration with advanced endoscopic platforms. Application-driven differences also matter: bariatric procedures often demand closure solutions that can withstand altered anatomy and high tissue stress, while gastrointestinal interventions emphasize closure reliability in friable or inflamed tissue and minimization of luminal obstruction.

Closure mechanisms further categorize offerings into adhesive and mechanical approaches. Adhesive closure includes injectable and topical adhesives, where injectables facilitate internal tissue approximation in confined spaces and topical formulations provide surface sealing and complement mechanical fixation. Mechanical closure divides into clip and suture closure, with clip closure offering rapid deployment and minimal device footprint, and suture closure enabling tailored approximation for larger defects or complex geometries. Material selection-metal versus polymer-intersects with these mechanisms, influencing imaging compatibility, tissue response, and long-term biocompatibility. Understanding these segmentation layers in combination reveals pockets of clinical need and design opportunity, as well as procurement preferences across care settings.

Regional dynamics and varying healthcare system priorities are defining differentiated adoption pathways and market entry strategies for closure technologies

Regional dynamics shape innovation, adoption, and commercial strategy for endoscopic closure devices, with distinctive patterns emerging across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, advanced procedural adoption and consolidated healthcare delivery networks create opportunities for devices that demonstrate operational efficiency and clear outcome advantages; conversely, cost containment pressures and payer scrutiny drive a focus on evidence generation and total episode-of-care value. The regulatory framework and reimbursement environment in this region place a premium on robust clinical data and clear procedural coding pathways.

Within Europe, Middle East & Africa, heterogeneity across national healthcare systems fosters a diverse market landscape. Western European markets often emphasize clinical guidelines alignment and centralized procurement practices, while emerging markets within the region present growth opportunities tied to capacity expansion and investments in procedural infrastructure. The regulatory and reimbursement mosaic necessitates tailored market entry strategies and flexible commercial models that reflect regional procurement norms and local evidence requirements.

Asia-Pacific exhibits a mix of rapid adoption in urban tertiary centers and expanding access in growing middle-income markets. Local manufacturing capabilities and price sensitivity influence procurement choices, while regulatory maturation in several countries increases expectations for device safety and post-market surveillance. Across all regions, strategic manufacturers balance global platform consistency with regional customization of product offerings, training programs, and pricing models to align with differing clinical practices and healthcare system priorities.

Competitive landscape characterized by scale-driven incumbents, agile innovators, and collaboration strategies that prioritize evidence, service, and system-level value

Competitive dynamics within the industry reflect a mix of established medical device manufacturers, niche specialists, and agile start-ups, each bringing different capabilities to innovation and market access. Established players often leverage scale, distribution networks, and integrated clinical support programs to secure placement in high-volume procedural centers. These organizations typically invest in incremental product improvements, broad clinical studies, and comprehensive training curricula that reduce adoption friction among multi-disciplinary teams.

Niche specialists and newer entrants frequently compete on technological novelty, focused application expertise, or cost-effective alternatives. Their strengths lie in rapid iteration, targeted clinical partnerships, and the ability to address specific unmet needs such as flexible delivery for tortuous anatomies or novel adhesive chemistries tuned for speed and biocompatibility. Collaboration between incumbents and innovators-through licensing, co-development, or acquisition-remains a common route to combine clinical credibility with technological differentiation.

Across the competitive set, value propositions are increasingly evaluated through the lens of system-level outcomes: procedural time savings, complication reduction, and compatibility with evolving endoscopic platforms. Companies that can pair compelling clinical evidence with scalable service models and supply chain resilience are better positioned to win preference among institutional buyers. Intellectual property positioning, regulatory experience, and demonstrable post-market performance form the pillars of sustained competitive advantage in this market.

Practical strategic moves for manufacturers and providers to align product development, evidence generation, and supply resilience with evolving clinical needs

Industry leaders can adopt a pragmatic set of actions to navigate clinical, commercial, and operational complexities while accelerating adoption of effective closure solutions. First, aligning R&D investments with demonstrable clinical needs-such as improving deployment reliability in inflamed tissue or creating lower-profile deliverability for tight anatomies-will improve uptake among high-volume centers. Prioritizing user-centered design and investing in simulator-based training modules can reduce learning curves and increase procedural consistency across operator skill levels.

Second, strengthening evidence generation through multi-center registries and pragmatic real-world studies will address payer and regulatory expectations for longitudinal outcomes. Embedding health economics and outcomes research into clinical programs enables stronger conversations with procurement organizations and supports differentiated reimbursement discussions. Third, rationalizing supply chains through supplier diversification, long-term contractual arrangements, and consideration of regional manufacturing can mitigate tariff exposure and logistics disruptions while improving responsiveness to demand variability.

Finally, commercial strategies should emphasize integrated offerings: combining device solutions with clinician education, procedural checklists, and post-market support enhances value perception beyond unit price. Strategic partnerships with endoscopy platform providers and clinical centers can create bundled solutions that simplify adoption. Leaders who execute these actions with cross-functional coordination among R&D, regulatory, supply chain, and commercial teams will be positioned to capture momentum as procedural volumes and clinical expectations continue to evolve.

A rigorous mixed-methods research framework combining primary clinical insight, regulatory review, and supply chain mapping to ensure actionable and validated findings

The research underpinning this analysis integrates a mixed-methods approach designed to produce robust, actionable insights while maintaining transparency and reproducibility. Primary research included in-depth interviews with practicing endoscopists, surgical leaders, procurement officers, and device developers to capture firsthand perspectives on clinical needs, device performance, and procurement decision drivers. These qualitative inputs were triangulated with device instruction for use documentation, regulatory filings, and peer-reviewed clinical literature to validate performance claims and identify gaps in evidence.

Secondary research encompassed a systematic review of clinical guidelines, regulatory announcements, and policy shifts affecting device access and post-market surveillance. Supply chain mapping drew on publicly available customs and trade data, provider procurement practices, and manufacturing disclosures to identify sourcing patterns and potential tariff sensitivities. Throughout the process, methodological rigor was maintained through standardized interview guides, thematic coding of qualitative data, and cross-checks between independent research analysts to reduce bias.

Limitations were managed through sensitivity to regional heterogeneity and the evolving regulatory environment; where variability existed, findings were contextualized with scenario-based implications rather than definitive projections. Ethical research practices guided participant engagement, and data integrity was preserved through secure handling and anonymization of primary interview material. This layered methodology ensures that conclusions reflect both practitioner realities and documented evidence, providing a sound basis for strategic decision-making.

Converging technical, clinical, and operational priorities indicate that integrated evidence-led strategies will determine success in the evolving closure device market

The trajectory of endoscopic closure devices will be shaped by the intersection of clinical innovation, evidence expectations, and operational imperatives. As procedural complexity grows and healthcare stakeholders demand demonstrable value, successful device strategies will hinge on delivering consistent clinical performance, supporting adoption with meaningful education, and maintaining resilient supply chains. Material science advances, refined delivery mechanisms, and tighter integration with endoscopic platforms will continue to expand clinical utility, but these technical gains must be accompanied by rigorous evidence of system-level benefits to secure broad adoption.

Stakeholders across the ecosystem-manufacturers, clinicians, and healthcare purchasers-stand to benefit from closer collaboration that aligns device capabilities with real-world procedural workflows and reimbursement models. Companies that invest in post-market data collection and pragmatic clinical studies will be better positioned to navigate regulatory scrutiny and payer engagement. At the same time, operational measures such as supplier diversification and regionally optimized production can reduce exposure to tariff-driven disruptions and logistics challenges.

In sum, the future of closure devices resides in the ability of market participants to marry technical innovation with practical execution: delivering solutions that are clinically credible, economically sensible, and operationally reliable will define winners in this evolving field.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Endoscopic Closure Devices Market, by Product Type

  • 8.1. Clips
    • 8.1.1. Metal Clips
    • 8.1.2. Polymer Clips
  • 8.2. Sealants
    • 8.2.1. Fibrin Sealants
    • 8.2.2. Synthetic Adhesives
  • 8.3. Sutures
    • 8.3.1. Absorbable Sutures
    • 8.3.2. Non Absorbable Sutures

9. Endoscopic Closure Devices Market, by Closure Mechanism

  • 9.1. Adhesive Closure
    • 9.1.1. Injectable Adhesives
    • 9.1.2. Topical Adhesives
  • 9.2. Mechanical Closure
    • 9.2.1. Clip Closure
    • 9.2.2. Suture Closure

10. Endoscopic Closure Devices Market, by Material

  • 10.1. Metal
  • 10.2. Polymer

11. Endoscopic Closure Devices Market, by Application

  • 11.1. Bariatric
  • 11.2. Gastrointestinal

12. Endoscopic Closure Devices Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Clinics
  • 12.3. Hospitals

13. Endoscopic Closure Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Endoscopic Closure Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Endoscopic Closure Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Endoscopic Closure Devices Market

17. China Endoscopic Closure Devices Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbott Laboratories
  • 18.6. Ackermann Instrumente GmbH
  • 18.7. Ambu A/S
  • 18.8. Apollo Endosurgery Inc
  • 18.9. B. Braun Melsungen AG
  • 18.10. Boston Scientific Corporation
  • 18.11. Cardinal Health Inc
  • 18.12. CONMED Corporation
  • 18.13. Cook Medical LLC
  • 18.14. CooperSurgical Inc
  • 18.15. ENDO-FLEX GmbH
  • 18.16. EndoGastric Solutions Inc
  • 18.17. Ethicon Inc
  • 18.18. Fujifilm Holdings Corporation
  • 18.19. Hoya Corporation
  • 18.20. Karl Storz SE & Co. KG
  • 18.21. Medtronic plc
  • 18.22. Meril Life Sciences Pvt. Ltd.
  • 18.23. Micro-Tech Endoscopy USA Inc
  • 18.24. Olympus Corporation
  • 18.25. Ovesco Endoscopy AG
  • 18.26. Richard Wolf GmbH
  • 18.27. Smith & Nephew plc
  • 18.28. STERIS plc
  • 18.29. Teleflex Inc

LIST OF FIGURES

  • FIGURE 1. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLIPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLIPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLIPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLIPS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY METAL CLIPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY METAL CLIPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY METAL CLIPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY POLYMER CLIPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY POLYMER CLIPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY POLYMER CLIPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SEALANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SEALANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SEALANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SEALANTS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY FIBRIN SEALANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY FIBRIN SEALANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY FIBRIN SEALANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SYNTHETIC ADHESIVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SYNTHETIC ADHESIVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SYNTHETIC ADHESIVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SUTURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SUTURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SUTURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY ABSORBABLE SUTURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY ABSORBABLE SUTURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY ABSORBABLE SUTURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY NON ABSORBABLE SUTURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY NON ABSORBABLE SUTURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY NON ABSORBABLE SUTURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY ADHESIVE CLOSURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY ADHESIVE CLOSURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY ADHESIVE CLOSURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY ADHESIVE CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY INJECTABLE ADHESIVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY INJECTABLE ADHESIVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY INJECTABLE ADHESIVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY TOPICAL ADHESIVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY TOPICAL ADHESIVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY TOPICAL ADHESIVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MECHANICAL CLOSURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MECHANICAL CLOSURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MECHANICAL CLOSURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MECHANICAL CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLIP CLOSURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLIP CLOSURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLIP CLOSURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SUTURE CLOSURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SUTURE CLOSURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SUTURE CLOSURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY METAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY METAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY METAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY POLYMER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY POLYMER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY POLYMER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY BARIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY BARIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY BARIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY GASTROINTESTINAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY GASTROINTESTINAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY GASTROINTESTINAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLIPS, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SEALANTS, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY ADHESIVE CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MECHANICAL CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLIPS, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SEALANTS, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY ADHESIVE CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MECHANICAL CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLIPS, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SEALANTS, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY ADHESIVE CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MECHANICAL CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLIPS, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SEALANTS, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY ADHESIVE CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MECHANICAL CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLIPS, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SEALANTS, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY ADHESIVE CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MECHANICAL CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLIPS, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SEALANTS, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY ADHESIVE CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MECHANICAL CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLIPS, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SEALANTS, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY ADHESIVE CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MECHANICAL CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLIPS, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SEALANTS, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY ADHESIVE CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MECHANICAL CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLIPS, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SEALANTS, 2018-2032 (USD MILLION)
  • TABLE 172. ASEAN ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 173. ASEAN ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY ADHESIVE CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MECHANICAL CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 176. ASEAN ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. GCC ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. GCC ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. GCC ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLIPS, 2018-2032 (USD MILLION)
  • TABLE 182. GCC ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SEALANTS, 2018-2032 (USD MILLION)
  • TABLE 183. GCC ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 184. GCC ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 185. GCC ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY ADHESIVE CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 186. GCC ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MECHANICAL CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 187. GCC ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 188. GCC ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 189. GCC ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPEAN UNION ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLIPS, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPEAN UNION ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SEALANTS, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPEAN UNION ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPEAN UNION ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY ADHESIVE CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MECHANICAL CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPEAN UNION ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 201. BRICS ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. BRICS ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. BRICS ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLIPS, 2018-2032 (USD MILLION)
  • TABLE 204. BRICS ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SEALANTS, 2018-2032 (USD MILLION)
  • TABLE 205. BRICS ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 206. BRICS ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY ADHESIVE CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 208. BRICS ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MECHANICAL CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 209. BRICS ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 211. BRICS ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 212. G7 ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 213. G7 ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. G7 ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLIPS, 2018-2032 (USD MILLION)
  • TABLE 215. G7 ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SEALANTS, 2018-2032 (USD MILLION)
  • TABLE 216. G7 ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 217. G7 ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 218. G7 ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY ADHESIVE CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 219. G7 ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MECHANICAL CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 220. G7 ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 221. G7 ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 222. G7 ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 223. NATO ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 224. NATO ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. NATO ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLIPS, 2018-2032 (USD MILLION)
  • TABLE 226. NATO ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SEALANTS, 2018-2032 (USD MILLION)
  • TABLE 227. NATO ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 228. NATO ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 229. NATO ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY ADHESIVE CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 230. NATO ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MECHANICAL CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 231. NATO ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 232. NATO ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 233. NATO ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 234. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 235. UNITED STATES ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 236. UNITED STATES ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. UNITED STATES ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLIPS, 2018-2032 (USD MILLION)
  • TABLE 238. UNITED STATES ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SEALANTS, 2018-2032 (USD MILLION)
  • TABLE 239. UNITED STATES ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 240. UNITED STATES ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED STATES ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY ADHESIVE CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 242. UNITED STATES ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MECHANICAL CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 243. UNITED STATES ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED STATES ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 245. UNITED STATES ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 246. CHINA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 247. CHINA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 248. CHINA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLIPS, 2018-2032 (USD MILLION)
  • TABLE 249. CHINA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SEALANTS, 2018-2032 (USD MILLION)
  • TABLE 250. CHINA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 251. CHINA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 252. CHINA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY ADHESIVE CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 253. CHINA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MECHANICAL CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 254. CHINA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 255. CHINA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 256. CHINA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)